OQROStart free trial
Politician trade (House)

Abbott Laboratories (ABT): Rep. Julie Johnson (TX32) disclosed a partial sale $1K–$15K

Rep. Julie Johnson (TX32) disclosed a partial sale of Abbott Laboratories in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
28 days
Disclosure lag
Traded
Nov 13, 2025
Disclosed
Dec 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 15, 2023CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  2. Oct 23, 2024CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  3. Sep 17, 2025FDAFDA device clearance: Assert-IQ (DM5000); Assert-IQ (DM5300); Assert-IQ (DM5500); Merlin.net (MN7000)
  4. Sep 18, 2025FDARecall: Brand Name: Alinity hq Analyzer Product Name: Alinity hq Analyzer Model/Catalog Number: 09P68-01 Software Version: 5.0 to 5.10.1 for OUS, 5.7 and 5.10.1 in the…
  5. Sep 25, 2025FDAFDA device clearance: Alinity m HCV
  6. Sep 25, 2025FDAFDA device clearance: EnSite™ X EP System
  7. Oct 3, 2025FDAFDA device clearance: Amplatzer Guidewire
  8. Oct 6, 2025FDARecall: Eterna SCS IPG (Implantable Pulse Generator), Model Number 32400
  9. Oct 6, 2025FDARecall: Liberta RC DBS IPG (Implantable Pulse Generator), Model Number 62400
  10. Oct 6, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  11. Oct 15, 2025Company filing · Form 8-K · ResultsReported its results
  12. Oct 29, 2025FDAFDA device clearance: Seguin Annuloplasty Ring
  13. Nov 5, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  14. Nov 13, 2025 · this disclosureCongressDisclosed partial sale of ABT — reported range $1,001 - $15,000

What came next

  1. Nov 13, 2025FDARecall: Alinity ci-series System Control Module (SCM), REF: 03R70-01, 03R70-20
  2. Nov 18, 2025Company filing · Form 8-K · Temporary Suspension of Trading Under Registrant's Employee Benefit PlansSuspended trading under its employee plans
  3. Nov 18, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  4. Nov 19, 2025Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
  5. Nov 24, 2025FDARecall: FreeStyle Libre 3 Sensor REF 72081-01 UDI-DI code: 00357599818005 The FreeStyle Libre 3 sensor is a component of the FreeStyle Libre 3 Continuous Glucose Monit…
  6. Nov 25, 2025InsiderOfficer sold ~$203K of ABT shares in the open market
  7. Dec 3, 20255% stakeThe Vanguard Group reported a passive stake (13G) of 10.1%
  8. Dec 4, 2025Congress · 1 personMembers of Congress: 2 sales
  9. Dec 8, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  10. Dec 12, 2025Company filing · Form 8-K · Executive change, Bylaws or charterChanged a top executive or board member, and changed its bylaws, charter or fiscal year“On December 12, 2025, Nita Ahuja, M.D. was named to the Abbott Laboratories’ (“Abbott”) Board of Directors.”
  11. Dec 17, 2025FDAFDA device clearance: Amplatzer Piccolo™ Delivery System (9-PDS-04F-045)
  12. Dec 18, 2025FDAFDA device clearance: Assert-IQ (DM5100)
  13. Dec 18, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  14. Dec 19, 2025FDAFDA device approval: Volt™ PFA System
  15. Dec 19, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
  16. Jan 22, 2026Company filing · Form 8-K · ResultsReported its results
  17. Jan 23, 2026Insider · First insider buy since Feb 2021CEO purchased ~$2.01M of ABT shares in the open market
  18. Jan 29, 2026CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  19. Feb 4, 2026Insider · 1 personInsiders: 2 purchases (~$1.1M)
  20. Feb 10, 2026CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 6 Congress trade reports and 59 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Rep. Julie Johnson (TX32)

The full history of Rep. Julie Johnson (TX32) is on the profile page.

How this filing works

Explore the data

Other disclosures at Abbott Laboratories

Everything OQRO holds on this company is on its ABT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data